291 related articles for article (PubMed ID: 15175980)
1. [Nerve growth factor in neurodegeneration and neurorestorative therapy].
Lorigados-Pedre L; Bergado-Rosado J
Rev Neurol; 2004 May 16-31; 38(10):957-71. PubMed ID: 15175980
[TBL] [Abstract][Full Text] [Related]
2. [Nerve growth factor: possibilities and limitations of its clinical application].
Castellanos-Ortega MR; Cruz-Aguado R; Martínez-Martí L
Rev Neurol; 1999 Sep 1-15; 29(5):439-47. PubMed ID: 10584248
[TBL] [Abstract][Full Text] [Related]
3. [Neuronal growth factors--neurotrophins].
Meyer M; Rasmussen JZ
Ugeskr Laeger; 1999 Apr; 161(14):2063-70. PubMed ID: 10354791
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence.
Lambiase A; Pagani L; Di Fausto V; Sposato V; Coassin M; Bonini S; Aloe L
Brain Res; 2007 Jan; 1127(1):45-51. PubMed ID: 17113055
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 in APP23 transgenic mice.
Schulte-Herbrüggen O; Eckart S; Deicke U; Kühl A; Otten U; Danker-Hopfe H; Abramowski D; Staufenbiel M; Hellweg R
J Neurosci Res; 2008 Sep; 86(12):2774-83. PubMed ID: 18438945
[TBL] [Abstract][Full Text] [Related]
6. Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases.
Wyman T; Rohrer D; Kirigiti P; Nichols H; Pilcher K; Nilaver G; Machida C
Gene Ther; 1999 Oct; 6(10):1648-60. PubMed ID: 10516713
[TBL] [Abstract][Full Text] [Related]
7. ProNGF, sortilin, and age-related neurodegeneration.
Al-Shawi R; Hafner A; Chun S; Raza S; Crutcher K; Thrasivoulou C; Simons P; Cowen T
Ann N Y Acad Sci; 2007 Nov; 1119():208-15. PubMed ID: 18056969
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
Popovic N; Brundin P
Int J Pharm; 2006 May; 314(2):120-6. PubMed ID: 16529886
[TBL] [Abstract][Full Text] [Related]
9. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
[TBL] [Abstract][Full Text] [Related]
10. Promoting neurotrophic effects by GPCR ligands.
Jeanneteau F; Chao MV
Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor: pathophysiological and therapeutic implications.
Hellweg R; Raivich G
Pharmacopsychiatry; 1994 Jul; 27 Suppl 1():15-7. PubMed ID: 7984691
[TBL] [Abstract][Full Text] [Related]
12. [Neurotrophic factors: basis for their clinical application].
Morís G; Vega JA
Neurologia; 2003; 18(1):18-28. PubMed ID: 12590377
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of the neurotrophins and their receptors.
Allen SJ; Dawbarn D
Clin Sci (Lond); 2006 Feb; 110(2):175-91. PubMed ID: 16411894
[TBL] [Abstract][Full Text] [Related]
14. BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures.
Kamei N; Tanaka N; Oishi Y; Hamasaki T; Nakanishi K; Sakai N; Ochi M
Spine (Phila Pa 1976); 2007 May; 32(12):1272-8. PubMed ID: 17515814
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve.
Tannemaat MR; Eggers R; Hendriks WT; de Ruiter GC; van Heerikhuize JJ; Pool CW; Malessy MJ; Boer GJ; Verhaagen J
Eur J Neurosci; 2008 Oct; 28(8):1467-79. PubMed ID: 18973572
[TBL] [Abstract][Full Text] [Related]
16. Olfactory ensheathing cells exert a trophic effect on the hypothalamic neurons in vitro.
Pellitteri R; Spatuzza M; Russo A; Stanzani S
Neurosci Lett; 2007 Apr; 417(1):24-9. PubMed ID: 17360117
[TBL] [Abstract][Full Text] [Related]
17. Advances in small molecules promoting neurotrophic function.
Price RD; Milne SA; Sharkey J; Matsuoka N
Pharmacol Ther; 2007 Aug; 115(2):292-306. PubMed ID: 17599430
[TBL] [Abstract][Full Text] [Related]
18. Influence of ischemic preconditioning on levels of nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors in hippocampus following forebrain ischemia.
Lee TH; Yang JT; Ko YS; Kato H; Itoyama Y; Kogure K
Brain Res; 2008 Jan; 1187():1-11. PubMed ID: 18036511
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophic factor therapy for nervous system degenerative diseases.
Hefti F
J Neurobiol; 1994 Nov; 25(11):1418-35. PubMed ID: 7852995
[TBL] [Abstract][Full Text] [Related]
20. The nerve growth factor and its receptors in airway inflammatory diseases.
Freund-Michel V; Frossard N
Pharmacol Ther; 2008 Jan; 117(1):52-76. PubMed ID: 17915332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
